Global Alzheimer's Disease Treatments Market Growth (Status and Outlook) 2019-2024
Table of Contents
2019-2024 Global Alzheimer's Disease Treatments Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Alzheimer's Disease Treatments Market Size 2014-2024
- 2.1.2 Alzheimer's Disease Treatments Market Size CAGR by Region
- 2.2 Alzheimer's Disease Treatments Segment by Type
- 2.2.1 Cholinesterase Inhibitors
- 2.2.2 NMDA Antagonists
- 2.3 Alzheimer's Disease Treatments Market Size by Type
- 2.3.1 Global Alzheimer's Disease Treatments Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Alzheimer's Disease Treatments Market Size Growth Rate by Type (2014-2019)
- 2.4 Alzheimer's Disease Treatments Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Diagnostic Laboratories
- 2.4.3 Research and Academic Laboratories
- 2.4.4 Others
- 2.5 Alzheimer's Disease Treatments Market Size by Application
- 2.5.1 Global Alzheimer's Disease Treatments Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Alzheimer's Disease Treatments Market Size Growth Rate by Application (2014-2019)
3 Global Alzheimer's Disease Treatments by Players
- 3.1 Global Alzheimer's Disease Treatments Market Size Market Share by Players
- 3.1.1 Global Alzheimer's Disease Treatments Market Size by Players (2017-2019)
- 3.1.2 Global Alzheimer's Disease Treatments Market Size Market Share by Players (2017-2019)
- 3.2 Global Alzheimer's Disease Treatments Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Alzheimer's Disease Treatments by Regions
- 4.1 Alzheimer's Disease Treatments Market Size by Regions
- 4.2 Americas Alzheimer's Disease Treatments Market Size Growth
- 4.3 APAC Alzheimer's Disease Treatments Market Size Growth
- 4.4 Europe Alzheimer's Disease Treatments Market Size Growth
- 4.5 Middle East & Africa Alzheimer's Disease Treatments Market Size Growth
5 Americas
- 5.1 Americas Alzheimer's Disease Treatments Market Size by Countries
- 5.2 Americas Alzheimer's Disease Treatments Market Size by Type
- 5.3 Americas Alzheimer's Disease Treatments Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Alzheimer's Disease Treatments Market Size by Countries
- 6.2 APAC Alzheimer's Disease Treatments Market Size by Type
- 6.3 APAC Alzheimer's Disease Treatments Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Alzheimer's Disease Treatments by Countries
- 7.2 Europe Alzheimer's Disease Treatments Market Size by Type
- 7.3 Europe Alzheimer's Disease Treatments Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Alzheimer's Disease Treatments by Countries
- 8.2 Middle East & Africa Alzheimer's Disease Treatments Market Size by Type
- 8.3 Middle East & Africa Alzheimer's Disease Treatments Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Alzheimer's Disease Treatments Market Forecast
- 10.1 Global Alzheimer's Disease Treatments Market Size Forecast (2019-2024)
- 10.2 Global Alzheimer's Disease Treatments Forecast by Regions
- 10.2.1 Global Alzheimer's Disease Treatments Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Alzheimer's Disease Treatments Forecast by Type
- 10.8 Global Alzheimer's Disease Treatments Forecast by Application
11 Key Players Analysis
- 11.1 Eisai
- 11.1.1 Company Details
- 11.1.2 Alzheimer's Disease Treatments Product Offered
- 11.1.3 Eisai Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Eisai News
- 11.2 Forest Laboratories
- 11.2.1 Company Details
- 11.2.2 Alzheimer's Disease Treatments Product Offered
- 11.2.3 Forest Laboratories Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Forest Laboratories News
- 11.3 H. Lundbeck
- 11.3.1 Company Details
- 11.3.2 Alzheimer's Disease Treatments Product Offered
- 11.3.3 H. Lundbeck Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 H. Lundbeck News
- 11.4 Johnson and Johnson
- 11.4.1 Company Details
- 11.4.2 Alzheimer's Disease Treatments Product Offered
- 11.4.3 Johnson and Johnson Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Johnson and Johnson News
- 11.5 Merz Pharma
- 11.5.1 Company Details
- 11.5.2 Alzheimer's Disease Treatments Product Offered
- 11.5.3 Merz Pharma Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Merz Pharma News
- 11.6 Novartis
- 11.6.1 Company Details
- 11.6.2 Alzheimer's Disease Treatments Product Offered
- 11.6.3 Novartis Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Novartis News
- 11.7 Pfizer
- 11.7.1 Company Details
- 11.7.2 Alzheimer's Disease Treatments Product Offered
- 11.7.3 Pfizer Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Pfizer News
...
12 Research Findings and Conclusion
Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time.
According to this study, over the next five years the Alzheimer's Disease Treatments market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Alzheimer's Disease Treatments business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Alzheimer's Disease Treatments market by product type, application, key companies and key regions.
This study considers the Alzheimer's Disease Treatments value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Cholinesterase Inhibitors
NMDA Antagonists
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Eisai
Forest Laboratories
H. Lundbeck
Johnson and Johnson
Merz Pharma
Novartis
Pfizer
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Alzheimer's Disease Treatments market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Alzheimer's Disease Treatments market by identifying its various subsegments.
Focuses on the key global Alzheimer's Disease Treatments players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Alzheimer's Disease Treatments with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Alzheimer's Disease Treatments submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.